4Monnier V M, Sell D R, Nagaraj R H, et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia [Jl. Diabetes, 1992, 41(supp12):36.
5Monnier V M, Vishwanath V, Frank K E, et al. Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence [ J]. N Engl J Med, 1986,314(7) : 403.
6Vlassara H, Bucala R, Strikerl. Patheogenic effects of advanced glycosylation: Biochemical, biologic and clinical implications for diabetes and aging [ J ]. Lab Invest, 1994,70:138.
7Niwa T. Dialysis-related amyloidosis: pathogenesis focusing on AGE modification [J]. Semin Dial, 2001, 14(2) : 114.
8Bonnardel-Phu E, Wantier J L, Vicaut E, et al. Advanced glycation end products are involved in microvascular permeability changes observed in microcirculation of diabetic rats in vivo [ J ]. J Mal Vasc, 2000, 25(2):122.
9Amano S, Kaji Y, Oshika T, et al. Advanced glycation end products in human optic nerve head [ J]. Br J Ophalmal, 2001,85 ( 1 ) :52.
10Fridman E A. Advanced glycosylated end produncts and hyperglycemia in the pathogenesis of diabetic complications [ J]. Diabetes Care, 1999, 22( suppl 2) : B65.
